BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30442505)

  • 1. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a trans-alkene spacer as potent GABA uptake inhibitors.
    Tóth K; Höfner G; Wanner KT
    Bioorg Med Chem; 2018 Dec; 26(22):5944-5961. PubMed ID: 30442505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with a cis-alkene spacer as GABA uptake inhibitors.
    Tóth K; Höfner G; Wanner KT
    Bioorg Med Chem; 2019 Mar; 27(5):822-831. PubMed ID: 30718063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel N-substituted nipecotic acid derivatives with an alkyne spacer as GABA uptake inhibitors.
    Tóth K; Höfner G; Wanner KT
    Bioorg Med Chem; 2018 Jul; 26(12):3668-3687. PubMed ID: 29886082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and screening of pseudostatic hydrazone libraries derived from 5-substituted nipecotic acid derivatives at the GABA transporter mGAT4.
    Hauke TJ; Höfner G; Wanner KT
    Bioorg Med Chem; 2019 Jan; 27(1):144-152. PubMed ID: 30503411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors.
    Quandt G; Höfner G; Wanner KT
    Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 4-substituted nipecotic acid derivatives and their evaluation as potential GABA uptake inhibitors.
    Hellenbrand T; Höfner G; Wein T; Wanner KT
    Bioorg Med Chem; 2016 May; 24(9):2072-96. PubMed ID: 27039250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Substituted Nipecotic Acids as (S)-SNAP-5114 Analogues with Modified Lipophilic Domains.
    Böck MC; Höfner G; Wanner KT
    ChemMedChem; 2020 May; 15(9):756-771. PubMed ID: 32187815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Biological Evaluation of Nipecotic Acid and Guvacine Derived 1,3-Disubstituted Allenes as Inhibitors of Murine GABA Transporter mGAT1.
    Schaarschmidt M; Höfner G; Wanner KT
    ChemMedChem; 2019 Jun; 14(12):1135-1151. PubMed ID: 30957949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.
    Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M
    Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives with N-Arylalkynyl Substituents.
    Lutz T; Wein T; Höfner G; Wanner KT
    ChemMedChem; 2017 Mar; 12(5):362-371. PubMed ID: 28125164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an (S)-1-{2-[tris(4-methoxyphenyl)methoxy]ethyl}piperidine-3-carboxylic acid [(S)-SNAP-5114] carba analogue inhibitor for murine γ-aminobutyric acid transporter type 4.
    Pabel J; Faust M; Prehn C; Wörlein B; Allmendinger L; Höfner G; Wanner KT
    ChemMedChem; 2012 Jul; 7(7):1245-55. PubMed ID: 22544452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS-Based Screening of 5-Substituted Nipecotic Acid Derived Hydrazone Libraries as Ligands of the GABA Transporter 1.
    Hauke TJ; Höfner G; Wanner KT
    ChemMedChem; 2019 Mar; 14(5):583-593. PubMed ID: 30663849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First photoswitchable neurotransmitter transporter inhibitor: light-induced control of γ-aminobutyric acid transporter 1 (GAT1) activity in mouse brain.
    Quandt G; Höfner G; Pabel J; Dine J; Eder M; Wanner KT
    J Med Chem; 2014 Aug; 57(15):6809-21. PubMed ID: 25025595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of a series of N-alkylated imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
    Kerscher-Hack S; Renukappa-Gutke T; Höfner G; Wanner KT
    Eur J Med Chem; 2016 Nov; 124():852-880. PubMed ID: 27654218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Highly Potent GAT1 Inhibitors: Synthesis of Nipecotic Acid Derivatives by Suzuki-Miyaura Cross-Coupling Reactions.
    Petrera M; Wein T; Allmendinger L; Sindelar M; Pabel J; Höfner G; Wanner KT
    ChemMedChem; 2016 Mar; 11(5):519-38. PubMed ID: 26683881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3.
    Damgaard M; Al-Khawaja A; Vogensen SB; Jurik A; Sijm M; Lie ME; Bæk MI; Rosenthal E; Jensen AA; Ecker GF; Frølund B; Wellendorph P; Clausen RP
    ACS Chem Neurosci; 2015 Sep; 6(9):1591-9. PubMed ID: 26154082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminomethyltetrazoles as potential inhibitors of the γ-aminobutyric acid transporters mGAT1-mGAT4: synthesis and biological evaluation.
    Schaffert ES; Höfner G; Wanner KT
    Bioorg Med Chem; 2011 Nov; 19(21):6492-504. PubMed ID: 21940173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors.
    Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B
    Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, Evaluation and Computational Studies of Nipecotic Acid-Acetonaphthone Hybrids as Potential Antiepileptic Agents.
    Seth A; Sharma PA; Tripathi A; Choubey PK; Srivastava P; Tripathi PN; Shrivastava SK
    Med Chem; 2018; 14(4):409-426. PubMed ID: 29336266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel GABA uptake inhibitors. 4. Bioisosteric transformation and successive optimization of known GABA uptake inhibitors leading to a series of potent anticonvulsant drug candidates.
    Andersen KE; Sørensen JL; Huusfeldt PO; Knutsen LJ; Lau J; Lundt BF; Petersen H; Suzdak PD; Swedberg MD
    J Med Chem; 1999 Oct; 42(21):4281-91. PubMed ID: 10543872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.